Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601

Background Perioperative chemotherapy is the standard of care for locally advanced gastric cancer (LAGC). This phase II study investigated the efficacy and safety of S-1 and oxaliplatin (SOX) as neoadjuvant chemotherapy (NAC) for LAGC and esophagogastric junction cancer (EGJC). Methods Patients comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2022, Vol.25 (1), p.180-187
Hauptverfasser:	Iwatsuki, Masaaki, Orita, Hiroyuki, Kobayashi, Kazuma, Hidaka, Shigekazu, Arigami, Takaaki, Kusumoto, Tetsuya, Satake, Hironaga, Oki, Eiji, Tsutsumi, Satoshi, Tobimatsu, Kazutoshi, Shimokawa, Mototsugu, Saeki, Hiroshi, Makiyama, Akitaka, Baba, Hideo, Mori, Masaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Surgery Adenocarcinoma Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adenocarcinoma - surgery Anastomosis Anastomotic leak Antineoplastic Combined Chemotherapy Protocols - therapeutic use Appetite loss Cancer Research Chemotherapy Chemotherapy, Adjuvant Diarrhea Esophagogastric Junction - pathology Gastrectomy Gastric cancer Gastroenterology Humans Medicine Medicine & Public Health Neoadjuvant Therapy Neutropenia Oncology Original Article Oxaliplatin Oxonic Acid Patients Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Stomach Neoplasms - surgery Surgery Surgical Oncology Survival Tegafur Thrombocytopenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!